Sanofi India Limited (SIL) has announced the appointment of Deepak Arora as its new Managing Director, effective October 27, 2025, following the recommendation of the Nomination and Remuneration Committee and subject to approvals from shareholders and the Central Government. 

 With over 30 years of global experience in the pharmaceutical and healthcare industry across North America, Europe, the Middle East, and Africa, Arora brings a wealth of leadership expertise spanning commercial strategy, sales, marketing, and general management.

His track record includes driving sustainable growth and leading successful business transformations for several multinational organizations.  In his new role, Arora will be responsible for shaping Sanofi India’s strategic vision in alignment with the company’s global priorities.

He will focus on accelerating innovation, enhancing organizational agility, and ensuring operational excellence across all business functions.

A strong advocate of inclusivity, he will also champion Sanofi’s Diversity, Equity, and Inclusion (DEI) culture within the organization. 

Welcoming the appointment, Aditya Narayan, Chairman of the Board, Sanofi India Limited, said: “On behalf of the Board of Directors, I am delighted to welcome Deepak Arora as the Managing Director. His extensive pharmaceutical experience across diverse geographies aligns perfectly with our endeavour to serve patients throughout India. We are confident that under his leadership, Sanofi will continue to thrive and innovate. We extend our wholehearted support and best wishes as he embarks on this significant journey.”

 Arora, who holds a Bachelor’s degree in Botany and Zoology from the University of Lucknow and an MBA from Indira Gandhi National Open University, expressed enthusiasm for his new role, emphasizing his commitment to advancing Sanofi’s mission to improve healthcare access and outcomes for patients across India. 

His appointment marks a pivotal moment for Sanofi India as it continues to strengthen its leadership in the pharmaceutical sector and drive meaningful healthcare innovation tailored to the needs of Indian patients.